Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-10T05:33:54.322Z Has data issue: false hasContentIssue false
  • English
  • Français

Landmark lecture on interventional cardiology: interventional cardiac catheterisation for CHD: the past, present, and the future*

Published online by Cambridge University Press:  29 December 2017

Ziyad M. Hijazi  and
Damien Kenny
Ziyad M. Hijazi*
Affiliation:
Sidra Cardiac Program, Sidra Medical & Research Center, Doha, Qatar Weill Cornell Medicine, New York, New York, United States of America
Damien Kenny
Affiliation:
Our Lady’s Children’s Hospital, Dublin, Ireland
*
Correspondence to: Z. M. Hijazi, MD, MPH, Chair, Department of Pediatrics, Sidra Cardiac Program, Sidra Medical & Research Center, Doha, Qatar. Tel: +974 4003 6602; E-mail: zhijazi@sidra.org
Get access Rights & Permissions [Opens in a new window]

Abstract

CHD affects millions of patients worldwide. Interventional therapies for CHD goes back to the mid-1960s when Bill Rashkind performed balloon atrial septostomy on a cyanotic baby with transposition of the great vessels. This was followed by development of balloon catheters to perform balloon valvuloplasties and angioplasties in the early to late 1980s. Although King and Mills performed the first transcatheter closure of secundum atrial septal defect in the mid-1970s, this procedure was better realised in the mid-1990s. More intracardiac defect closures were performed in the late 1990s and early 2000. This brings us to the current era of percutaneous valve implantation as developed by Bonhoeffer. In this paper, we will discuss the past, present, and future of interventional cardiac catheterisation for CHD patients.

Keywords

Cardiac catheterizationcongenital heart diseasetranscatheter pulmonary valve replacement
Type
Original Articles
Information
Cardiology in the Young , Volume 27 , Special Issue 10: Proceedings of the 2017 7th World Congress of Pediatric Cardiology & Cardiac Surgery (WCPCCS 2017) Barcelona, Spain July 16–21, 2017 , December 2017 , pp. 1974 - 1985
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Presented at the 2017 Seventh World Congress of Pediatric Cardiology & Cardiac Surgery (WCPCCS 2017), Barcelona, Spain, 16–21 July, 2017. Presented Friday, 21 July, 2017.

References

1. Rashkind, WJ, Miller, WW. Creation of an atrial septal defect without thoracotomy: a palliative approach to complete transposition of the great arteries. JAMA. 1966; 196: 991–992.Google Scholar
2. Kan, JS, White, RI Jr, Mitchell, SE, Gardner, TJ. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med 1982; 307: 540–542.Google Scholar
3. Feltes, TF, Bacha, E, Beekman, RH, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 2606–2652.Google Scholar
4. Hijazi, ZM, Awad, SM. Pediatric cardiac interventions. JACC Cardiovasc Interv 2008; 1: 603–611.Google Scholar
5. Lababidi, Z. Aortic balloon valvuloplasty. Am Heart J 1983; 106: 751–752.Google Scholar
6. Qureshi, SA, Redington, AN, Wren, C, et al. Recommendations of the British Pediatric Cardiac Association for therapeutic cardiac catheterization in congenital heart disease. Cardiol Young 2000; 10: 649–667.Google Scholar
7. Porstmann, W, Wierny, L, Warnke, H. The closure of the patent arteriosus without thoracotomy. (preliminary report). Thoraxchir Vask Chir 1967; 15: 199–203.Google Scholar
8. Gatzoulis, MA, Rodington, AN, Somerville, J, Shore, DF. Should atrial septal defects in adults be closed? Ann Thorac Surg 1996; 61: 657–659.CrossRefGoogle ScholarPubMed
9. Silvestry, FE, Cohen, MS, Armsby, LB, et al. Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 2015; 28: 910–958.Google Scholar
10. Al-Hindi, A, Cao, QL, Hijazi, ZM. Transcatheter closure of secundum atrial septal defect in the elderly. J Invasive Cardiol 2009; 21: 70–75.Google Scholar
11. Du, ZD, Hijazi, ZM, Kleinman, CS, Silverman, NH, Larntz, K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter non-randomized trial. J Amer Coll Cardiol 2002; 39: 1836–1844.Google Scholar
12. Holzer, R, Balzer, D, Cao, QL, Lock, K, Hijazi, ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. Registry. J Amer Coll Cardiol 2004; 43: 1257–1263.CrossRefGoogle Scholar
13. Waight, DJ, Bacha, EA, Kahana, M, Cao, QL, Heitschmidt, M, Hijazi, ZM. Catheter therapy of Swiss Cheese ventricular septal defects using the Amplatzer MUSCULAR VSD occluder. Cath Cardiovasc Intervent 2002; 55: 355–361.Google Scholar
14. Fu, YC, Bass, J, Amin, Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder. J Amer Coll Cardiol 2006; 47: 319–325.CrossRefGoogle ScholarPubMed
15. Holzer, R, deGiovanni, J, Walsh, KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder: immediate and midterm results of an International Registry. Catheter Cardiovasc Intervent 2006; 68: 620–628.Google Scholar
16. Bacha, EA, Cao, QL, Starr, JP, Waight, DJ, Ebeid, MR, Hijazi, ZM. Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J Thorac Cardiovasc Surg 2003; 126: 1718–1723.Google Scholar
17. Holzer, R, Marshall, A, Kreutzer, J, et al. Hybrid procedures: adverse events and procedural characteristics-results of a multi-institutional registry. Congenit Heart Dis. 2010; 5: 233–242.Google Scholar
18. Mahle, WT, Spray, TL, Wernovsky, G, et al. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation 2000; 10: III136–III141.Google Scholar
19. Stasik, SN, Goldberg, CS, Bove, EL, et al. Current outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg 2006; 131: 412–417.Google Scholar
20. Ohye, RG, Sleeper, LA, Mahony, L, et al. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 2010; 362: 1980–1992.Google Scholar
21. Sarajuuri, A, Jokinen, E, Puosi, R, et al. Neurodevelopmental and neuroradiologic outcomes in patients with univentricular heart aged 5 to 7 years: related risk factor analysis. J Thorac Cardiovasc Surg 2007; 133: 1524–1532.Google Scholar
22. Gibbs, JL, Rothman, MT, Rees, MR, et al. Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J 1992; 67: 240–245.Google Scholar
23. Ruiz, CE, Gamra, H, Zhang, HP, et al. Stenting of the ductus arteriosus as a bridge to cardiac transplantation in infants with the hypoplastic left-heart syndrome. N Engl J Med 1993; 328: 1605–1608.Google Scholar
24. Gibbs, JL, Wren, C, Watterson, KG, et al. Stenting of the arterial duct combined with banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to palliation for the hypoplastic left heart syndrome. Br Heart J 1993; 69: 551–555.Google Scholar
25. Gibbs, JL, Uzun, O, Blackburn, ME, et al. Fate of the stented arterial duct. Circulation 1999; 99: 2621–2625.Google Scholar
26. Akintuerk, H, Michel-Behnke, I, Valeske, K, et al. Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation 2002; 105: 1099–1103.Google Scholar
27. Akintuerk, H, Michel-Behnke, I, Valeske, K, et al. Hybrid transcatheter-surgical palliation: basis for univentricular or biventricular repair: the Giessen experience. Pediatr Cardiol 2007; 28: 79–87.Google Scholar
28. Galantowicz, M, Cheatham, JP. Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatr Cardiol 2005; 26: 190–199.CrossRefGoogle ScholarPubMed
29. Galantowicz, M, Cheatham, JP, Phillips, A, et al. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg 2008; 85: 2063–2070.Google Scholar
30. Holzer, RJ, Wood, A, Chisolm, JL, et al. Atrial septal interventions in patients with hypoplastic left heart syndrome. Cathet Cardiovasc Interv 2008; 72: 696–704.Google Scholar
31. Stoica, SC, Philips, AB, Egan, M, et al. The retrograde aortic arch in the hybrid approach to hypoplastic left heart syndrome. Ann Thorac Surg 2009; 88: 1939–1946.CrossRefGoogle ScholarPubMed
32. Naguib, AN, Winch, P, Schwartz, L, et al. Anesthetic management of the hybrid stage 1 procedure for hypoplastic left heart syndrome (HLHS). Paediatr Anaesth 2010; 20: 38–46.CrossRefGoogle ScholarPubMed
33. Luce, WA, Schwartz, RM, Beauseau, W, et al. Necrotizing enterocolitis in neonates undergoing the hybrid approach to complex congenital heart disease. Pediatr Crit Care Med 2011; 12: 46–51.Google Scholar
34. Gafoor, S, Zahn, EM. Intraoperative stent implantation. In: Sievert H, Qureshi S, Wilson N, Hijazi ZM, (eds). Interventions in Structural, Valvular, and Congenital Heart Disease. Taylor and Francis Group, Boca Raton, FL, 2015: 777–791.Google Scholar
35. Bonhoeffer, P, Boudjemline, Y, Saliba, Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403–1405.Google Scholar
36. Malekzadeh-Milani, S, Ladouceur, M, Cohen, S, Iserin, L, Boudjemline, Y. Results of transcatheter pulmonary valvulation in native or patched right ventricular outflow tracts. Arch Cardiovasc Dis 2014; 107: 592–598.CrossRefGoogle ScholarPubMed
37. O’Byrne, ML, Glatz, AC, Mercer-Rosa, L, et al. Trends in pulmonary valve replacement in children and adults with tetralogy of fallot. Am J Cardiol 2015; 115: 118–124.Google Scholar
38. Quail, MA, Frigiola, A, Giardini, A, et al. Impact of pulmonary valve replacement in tetralogy of Fallot with pulmonary regurgitation: a comparison of intervention and nonintervention. Ann Thorac Surg 2012; 94: 1619–1626.Google Scholar
39. Baumgartner, H, Bonhoeffer, P, De Groot, NM, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915–2957.Google Scholar
40. Silversides, CK, Kiess, M, Beauchesne, L, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol 2010; 26: e80–e97.Google Scholar
41. Warnes, CA, Williams, RG, Bashore, TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008; 118: e714–e833.Google Scholar
42. Lee, C, Kim, YM, Lee, CH, et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol 2012; 60: 1005–1014.Google Scholar
43. Brown, DW, McElhinney, DB, Araoz, PA, et al. Reliability and accuracy of echocardiographic right heart evaluation in the U.S. Melody Valve Investigational Trial. J Am Soc Echocardiogr 2012; 25: 383–392.Google Scholar
44. Cheatham, SL, Holzer, RJ, Chisolm, JL, Cheatham, JP. The Medtronic Melody(R) transcatheter pulmonary valve implanted at 24-mm diameter – it works. Cathet Cardiovasc Interv 2013; 82: 816–823.CrossRefGoogle Scholar
45. Morray, BH, McElhinney, DB, Cheatham, JP, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv 2013; 6: 535–542.Google Scholar
46. Kenny, D, Hijazi, ZM, Kar, S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol 2011; 58: 2248–2256.Google Scholar
47. Butera, G, Milanesi, O, Spadoni, I, et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of pediatric cardiology. Catheter Cardiovasc Interv 2013; 81: 310–316.Google Scholar
48. Zahn, EM, Hellenbrand, WE, Lock, JE, McElhinney, DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the U.S. Clinical trial. J Am Coll Cardiol 2009; 54: 1722–1729.CrossRefGoogle ScholarPubMed
49. Sharma, A, Cote, AT, Hosking, MCK, Harris, KC. A systematic review of infective endocarditis in patients with bovine jugular vein valves compared with other valve types. JACC Cardiovasc Interv 2017; 10: 1449–1458.Google Scholar
50. Cao, QL, Kenny, D, Zhou, D, et al. Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv 2014; 84: 1131–1137.Google Scholar
51. Promphan, W, Prachasilchai, P, Siripornpitak, S, Qureshi, SA, Layangool, T. Percutaneous pulmonary valve implantation with the Venus P-valve: clinical experience and early results. Cardiol Young 2016; 26: 698–710.Google Scholar
52. Palmaz, JC, Sibbitt, RR, Reuter, SR, Garcia, F, Tio, FO. Expandable intrahepatic portocaval shunt stents: early experience in the dog. Am J Roentgenol 1985; 145: 821–825.Google Scholar
53. Palmaz, JC, Sibbitt, RR, Tio, FO, Reuter, SR, Peters, JE, Garcia, F. Expandable intraluminal vascular graft: a feasibility study. Surgery 1986; 99: 199–205.Google ScholarPubMed
54. O’Laughlin, MP, Perry, SB, Lock, JE, Mullins, CE. Use of endovascular stents in congenital heart disease. Circulation 1991; 83: 1923–1939.Google Scholar
55. Serruys, PW, Ormiston, JA, Onuma, Y, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009; 373: 897–910.CrossRefGoogle ScholarPubMed
56. Hausdorf, G, Schneider, M, Konertz, W. Surgical preconditioning and completion of total cavopulmonary connection by interventional cardiac catheterization: a new concept. Heart 1996; 75: 403–409.CrossRefGoogle ScholarPubMed